Home
Tests
Products
Companies
Technologies
Topics
Insights
Buyer's Guide
Partners

Home
Tests
Products
Companies
Technologies
Topics
Insights
Buyer's Guide
Partners

Loading

Loading

IVDmap

Global entry platform for product discovery, supplier mapping, and procurement decision support.

Platform

Home
Products
Companies
Technologies
Insights
Tools
Glossary

Buyers

Buyer's Guide
Resource Packs
Request Quote
Case Studies

Partners

Become a Partner
OEM Cooperation
Partner application

Company / Legal

Contact
Privacy
Terms
Disclaimer
[email protected]

Regulatory Notice Disclaimer Privacy TermsFor professional use only. Availability varies by country.

Search IVDmap

Search products, companies, tests, and guides — go from query to quote request in one place.

Search

Showing 1 - 6 of 6 for “Rifampicin-Resistant Mycobacterium tuberculosis Positive Control Panel (Inactivated Pellet)”

All Results (6)Article (6)

Article

Clinical Utility of Cartridge-Based Nucleic Acid Amplification Test for Tuberculosis and Rifampicin Resistance Detection in the Vindhya Region of India: A Retrospective Study.

Research record from Cureus, 2026-08-13. PMID 42732277.

Article

Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings.

Research record from Arch Bronconeumol, 2026-04-24. PMID 42135169.

Article

Implementation of next-generation sequencing to guide care and public health action in settings with high burden of rifampicin-resistant tuberculosis: 32 stakeholder consensus statements generated using Delphi principles.

Research record from BMJ Public Health, 2026-10-05. PMID 42852055.

Article

Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic Acid Amplification Test and Line Probe Assay.

Research record from Cureus, 2026-06-04. PMID 42403861.

Article

Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis - A qualitative study.

Research record from PLoS One, 2026-06-26. PMID 42360998.

Article

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Research record from Nat Commun, 2026-06-11. PMID 42270607.